Bio-Rad Laboratories | BIO - Debt


Bio-Rad Laboratories reported $1.39B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Agilent USD 3.35B 0 Dec/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Bio Techne USD 200M 60M Mar/2026
Bio-Rad Laboratories USD 1.39B 9.2M Dec/2025
Bruker USD 2.04B 34.4M Dec/2025
Charles River Laboratories USD 2.57B 58.23M Dec/2025
Danaher USD 18.48B 66M Mar/2026
General Electric Aerospace USD 19.16B 1.12B Jun/2026
Illumina USD 2.55B 23M Dec/2025
IQVIA Holdings USD 15.83B 109M Mar/2026
Laboratory Of America USD 6.53B 3.9M Dec/2025
Merck USD 49.34B 7.97B Dec/2025
Mettler Toledo International USD 2.15B 57.69M Dec/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
OraSure Technologies USD 782K 465K Jun/2024
Pacific Biosciences Of California USD 892.24M 653K Dec/2023
Quest Diagnostics USD 6.41B 179M Mar/2026
Repligen USD 546.58M 4.37M Mar/2026
Revvity USD 3.4B 29.2M Dec/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Siemens EUR 56.46B 450M Dec/2025
Standard Biotools USD 29.49M 2.1M Mar/2026
Thermo Fisher Scientific USD 39.39B 3.7B Dec/2025
Tosoh JPY 172.31B 6.79B Sep/2025
Waters USD 1.49B 4.92M Dec/2025